D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.

Saved in:
Bibliographic Details
Title: D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.
Authors: McKean WB; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Yang J; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Boucher K; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Department of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Shrieve DC; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Suneja G; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Salzman K; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Jensen R; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Cohen AL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Division of Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2024 Apr 23; Vol. 6 (1), pp. vdae063. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38800698
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McKean+WB%22">McKean WB</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Boucher+K%22">Boucher K</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Department of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Shrieve+DC%22">Shrieve DC</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Suneja+G%22">Suneja G</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Salzman+K%22">Salzman K</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Jensen+R%22">Jensen R</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Colman+H%22">Colman H</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+AL%22">Cohen AL</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Division of Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2024 Apr 23; Vol. 6 (1), pp. vdae063. <i>Date of Electronic Publication: </i>2024 Apr 23 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38800698
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdae063
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdae063
    Titles:
      – TitleFull: D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McKean WB
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Boucher K
      – PersonEntity:
          Name:
            NameFull: Shrieve DC
      – PersonEntity:
          Name:
            NameFull: Suneja G
      – PersonEntity:
          Name:
            NameFull: Salzman K
      – PersonEntity:
          Name:
            NameFull: Jensen R
      – PersonEntity:
          Name:
            NameFull: Colman H
      – PersonEntity:
          Name:
            NameFull: Cohen AL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 04
              Text: 2024 Apr 23
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1